Taking position: Effect of SGLT2i on arterial pressure, vascular damage, kidney disease and associated cardiovascular risk

被引：0

作者：

Inserra, Felipe ^{[1
,2
,3
,4
]}

Forte, Ezequiel ^{[5
]}

Elbert, Alicia ^{[6
]}

Waisman, Gabriel ^{[1
]}

Castellaro, Carlos ^{[3
]}

Buso, Carlos ^{[5
]}

Fairman, Enrique ^{[5
]}

Cobo, Augusto Lavalle ^{[5
]}

Manucha, Walter ^{[5
]}

Salmeri, Emiliano ^{[5
]}

Sanabria, Hugo ^{[5
]}

Sanchez, Ramiro ^{[5
]}

Terns, Paula Perez ^{[5
]}

Aranguren, Florencia ^{[6
]}

Arias, Pablo ^{[6
]}

Castano, Yanina ^{[6
]}

De Marziani, Guillermo ^{[6
]}

Faingold, Cristina ^{[6
]}

Gonzalez, Joaquin ^{[6
]}

Jawerbaum, Alicia ^{[6
]}

Vazquez, Fabiana ^{[6
]}

Wappner, Diego ^{[6
]}

Zaidel, Ezequiel J. ^{[6
]}

Aiello, Ernesto A. ^{[1
]}

Alfie, Jose ^{[1
]}

De Cerchio, Alejandro ^{[1
]}

Choi, Marcelo ^{[1
]}

Marquez, Diego ^{[1
]}

Piskorz, Daniel ^{[1
]}

Pupi, Luis Maria ^{[1
]}

Renna, Nicolas ^{[1
]}

Salazar, Martin ^{[1
]}

Dorado, Enrique ^{[3
]}

Ferder, Leon ^{[3
]}

Lavenia, Gustavo ^{[3
]}

Orias, Marcelo ^{[3
]}

Paganti, Luciana Gonzalez ^{[3
]}

Rigo, Diego H. ^{[3
]}

Diez, Guillermo Rosa ^{[3
]}

Sivak, Leonardo ^{[3
]}

Trimarchi, Hernan ^{[3
]}

Majul, Claudio ^{[5
]}

Sinay, Isaac ^{[5
]}

Marin, Marcos ^{[5
]}

Bonanno, Carlos ^{[5
]}

机构：

[1] Soc Argentina Hipertens Arterial, Buenos Aires, Argentina

[2] Com Salud Renal & Hipertens Arterial & Dano Vasc, Buenos Aires, Argentina

[3] Soc Argentina Nefrol, Buenos Aires, Argentina

[4] Univ Austral, Mecan Vasc Hipertens Arterial, Buenos Aires, Argentina

[5] Soc Argentina Cardiol, Buenos Aires, Argentina

[6] Soc Argentina Diabet, Buenos Aires, Argentina

来源：

REVISTA DE NEFROLOGIA DIALISIS Y TRASPLANTE | 2024年 / 44卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：49 / 51

页数：3

共 50 条

[21] Machine Learning to Identify Diabetes Patients Initiating SGLT2i at High-Risk of Acute Kidney Injury
Yang, Lanting
Gabriel, Nico
Hernandez, Inmaculada
Winterstein, Almut G.
Kimmel, Stephen
Guo, Jingchuan
DIABETES, 2021, 70
[22] Use of sodium-glucose cotransporter-2 inhibitors (SGLT2i) and risk of Parkinson's disease
Hsieh, Miyuki Hsing-Chun
Lai, Edward
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 274 - 275
[23] The Cardiovascular Benefits and Infections Risk of SGLT2i versus Metformin in Type 2 Diabetes: A Systemic Review and Meta-Analysis
Xu, Chunmei
He, Liping
Zhang, Jing
Xu, Lusi
Dong, Jianjun
Liao, Lin
METABOLITES, 2022, 12 (10)
[24] SGLT2i Treatment Reduces Cardiorenal Disease Risk in T2D Patients Without Established Cardiovascular and Renal Diseases: A Large Observational Study
Komuro, Issei
Bodegard, Johan
Thuresson, Marcus
Yajima, Toshitaka
Eriksson, Jan W.
Norhammar, Anna
Birkeland, Kare I.
Kadowaki, Takashi
CIRCULATION, 2019, 140 (25) : E980 - E980
[25] Anticipating the Impact of 2019 Guidelines: Use of SGLT2i and GLP-1RA in Patients with Diabetes and Cardiovascular Disease
Rattelman, Cori R.
Ciemins, Elizabeth L.
Cuddeback, John K.
DIABETES, 2019, 68
[26] Genetic Mimics of GLP-1Ra and SGLT2i Therapy, Heart Failure and Chronic Kidney Disease Outcomes
Remala, Subbaramireddy
Liang, Liming
Shah, Amil
Buckley, Leo
CIRCULATION, 2024, 150
[27] Effect of SGLT2i on kidney outcomes of individuals with type 2 diabetes according to body mass index: nationwide cohort study
Jimba, Takahiro
Kaneko, Hidehiro
Suzuki, Yuta
Okada, Akira
Azegami, Tatsuhiko
Ko, Toshiyuki
Fujiu, Katsuhito
Morita, Hiroyuki
Takeda, Norifumi
Hayashi, Kaori
Yokoo, Takashi
Node, Koichi
Komuro, Issei
Yasunaga, Hideo
Nangaku, Masaomi
Takeda, Norihiko
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2025, 11 (02) : 155 - 163
[28] Forecast of the Burden of chronic Kidney Disease on the German Health Care System and Modelling of the potential Impact of SGLT2i Treatment
Banas, Miriam C.
Burckhardt, Fabian
Sanchez, Juan Jose Garcia
Coker, Timothy
Retat, Lise
Davis, Jason A.
Morrin, Aisling
INNERE MEDIZIN, 2024, 65 : S145 - S146
[29] Hyperuricemia in Kidney Disease: A Major Risk Factor for Cardiovascular Events, Vascular Calcification, and Renal Damage
Ejaz, A. Ahsan
Nakagawa, Takahiko
Kanbay, Mehmet
Kuwabara, Masanari
Kumar, Ada
Garcia Arroyo, Fernando E.
Roncal-Jimenez, Carlos
Sasai, Fumihiko
Kang, Duk-Hee
Jensen, Thomas
Hernando, Ana Andres
Rodriguez-Iturbe, Bernardo
Garcia, Gabriela
Tolan, Dean R.
Sanchez-Lozada, Laura G.
Lanaspa, Miguel A.
Johnson, Richard J.
SEMINARS IN NEPHROLOGY, 2020, 40 (06) : 574 - 585
[30] Cholesin receptor signalling is active in cardiovascular system-associated adipose tissue and correlates with SGLT2i treatment in patients with diabetes
Ryk, Aleksandra
Marcinkiewicz, Anna
Chrzanowski, Jedrzej
Michalak, Arkadiusz Mariusz
Drozdz, Izabela
Burzynski, Jacek
Krejca, Michal
Fendler, Wojciech
CARDIOVASCULAR DIABETOLOGY, 2024, 23 (01)

← 1 2 3 4 5 →